Mingen Lin
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Transplantation top 10%
Papers in
-
- Epigenetics and DNA Methylation 4
- RNA modifications and cancer 3
- DNA Repair Mechanisms 2
- Oncology 5
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- Lei Lv (10 shared papers)Chuanmin Cheng (1 shared paper)Yan Lin (1 shared paper)Ming‐Liang Lai (1 shared paper)Jin‐ding Huang (1 shared paper)Yanping Xu (8 shared papers)Ruonan Zhang (6 shared papers)Wenjing Dong (2 shared papers)
- Journals
- Cell Death and Disease (2 papers)Molecular Therapy — Oncolytics (1 paper)Cell Reports (1 paper)Cell Discovery (1 paper)Journal of Clinical Investigation (1 paper)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Mingen Lin
17 papers receiving 470 citations
Mingen Lin's Hit Papers
Peers
Comparison fields: 5 of 78
- Pharmacology 135
- Transplantation 19
- Oncology 178
- Cancer Research 58
- Immunology 80
Countries citing papers authored by Mingen Lin
This map shows the geographic impact of Mingen Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingen Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingen Lin more than expected).
Fields of papers citing papers by Mingen Lin
This network shows the impact of papers produced by Mingen Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingen Lin. The network helps show where Mingen Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Mingen Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Novel mutations of CYP3A4 in Chinese. | 2001 | 161 |
| 2 | D-mannose facilitates immunotherapy and radiotherapy of triple-negative breast cancer via degradation of PD-L1 Hit paper breakdown → | 2022 | 160 |
| 3 | 2023 | 38 | |
| 4 | 2022 | 34 | |
| 5 | 2023 | 13 | |
| 6 | 2020 | 11 | |
| 7 | 2023 | 9 | |
| 8 | 2023 | 7 | |
| 9 | 2024 | 7 | |
| 10 | 2024 | 6 | |
| 11 | 2020 | 6 | |
| 12 | 1984 | 5 | |
| 13 | 2022 | 4 | |
| 14 | 1993 | 4 | |
| 15 | 2025 | 4 | |
| 16 | 2015 | 3 | |
| 17 | 2005 | 1 | |
| 18 | 2025 | 0 |
About Mingen Lin
Mingen Lin is a scholar working on Molecular Biology, Oncology, Cell Biology, Immunology and Epidemiology, having authored 18 papers that have together received 473 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Immune Cell Function and Interaction (3 papers), RNA modifications and cancer (3 papers), Endoplasmic Reticulum Stress and Disease (2 papers), Hippo pathway signaling and YAP/TAZ (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and DNA Repair Mechanisms (2 papers). The work is most often cited by research in Pharmacology (135 citations), Transplantation (19 citations), Oncology (178 citations), Cancer Research (58 citations) and Immunology (80 citations). Mingen Lin has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Lei Lv, Chuanmin Cheng, Yan Lin, Ming‐Liang Lai, Jin‐ding Huang, Yanping Xu, Ruonan Zhang, Wenjing Dong, Tongguan Tian and Jing He. Their work appears in journals such as Cell Death and Disease, Molecular Therapy — Oncolytics, Cell Reports, Cell Discovery and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.